Supernus Pharmaceuticals
SUPN
#4010
Rank
NZ$5.13 B
Marketcap
NZ$89.64
Share price
0.18%
Change (1 day)
32.78%
Change (1 year)

Market capitalization of Supernus Pharmaceuticals (SUPN)

Market cap: NZ$5.13 Billion

As of January 2026 Supernus Pharmaceuticals has a market cap of NZ$5.13 Billion. This makes Supernus Pharmaceuticals the world's 4010th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Supernus Pharmaceuticals from 2012 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$5.13 B0.67%
2025NZ$5.10 B40.25%
2024NZ$3.64 B45.61%
2023NZ$2.50 B-17.68%
2022NZ$3.03 B33.77%
2021NZ$2.27 B23.15%
2020NZ$1.84 B-0.36%
2019NZ$1.85 B-28.59%
2018NZ$2.59 B-9.92%
2017NZ$2.87 B59.28%
2016NZ$1.80 B87.65%
2015NZ$0.96 B111.39%
2014NZ$0.45 B24.09%
2013NZ$0.36 B37.46%
2012NZ$0.26 B

End of Day market cap according to different sources

On Jan 12th, 2026 the market cap of Supernus Pharmaceuticals was reported to be:

NZ$5.13 Billion
by Nasdaq info icon info icon
NZ$5.13 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Zogenix
ZGNX
NZ$2.61 B-49.15%๐Ÿ‡บ๐Ÿ‡ธ USA
United Therapeutics
UTHR
NZ$37.57 B 631.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$1.681 T 32,615.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$198.37 B 3,759.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$376.74 B 7,229.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$897.05 B 17,352.45%๐Ÿ‡บ๐Ÿ‡ธ USA